Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Blank

Showing results (11-20 of 89) with videos related to

Pageof 9
Sort By:
Annals of Hematology|May 4, 2007
Ifosfamide, epirubicin, and etoposide (IEV) mobilize peripheral blood stem cells more efficiently than cyclophosphamide/etoposideChristina Hart, Christian Blank, Stefan W Krause, et al.
Current Oncology Reports|February 25, 2012
Immunological heterogeneity of the RCC microenvironment: do targeted therapies influence immune response?Axel Bex, Tamara Etto, Florry Vyth-Dreese, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 22, 2003
Absence of programmed death receptor 1 alters thymic development and enhances generation of CD4/CD8 double-negative TCR-transgenic T cellsChristian Blank, Ian Brown, Reinhard Marks, et al.
European Journal of Immunology|August 7, 2009
Homeostatic proliferation of naïve CD8+ T cells depends on CD62L/L-selectin-mediated homing to peripheral LNKerstin Schuster, Jules Gadiot, Reinhard Andreesen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 8, 2005
ICAM-1 contributes to but is not essential for tumor antigen cross-priming and CD8+ T cell-mediated tumor rejection in vivoChristian Blank, Ian Brown, Aalok K Kacha, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2006
Homeostatic proliferation as an isolated variable reverses CD8+ T cell anergy and promotes tumor rejectionIan E Brown, Christian Blank, Justin Kline, et al.
Urology|August 2, 2011
A phase II study of presurgical sunitinib in patients with metastatic clear-cell renal carcinoma and the primary tumor in situAxel Bex, Christian Blank, Wim Meinhardt, et al.
World Journal of Urology|February 3, 2016
Comparison of pre-treatment MSKCC and IMDC prognostic risk models in patients with synchronous metastatic renal cell carcinoma treated in the era of targeted therapyAllard Noe, Roderick E de Bruijn, Christian Blank, et al.
Immunological Reviews|September 16, 2006
Immune resistance orchestrated by the tumor microenvironmentThomas F Gajewski, Yuru Meng, Christian Blank, et al.
American Journal of Medical Genetics. Part A|December 12, 2002
Molecular cytogenetic analysis of a constitutional de novo interstitial deletion of chromosome 12p in a boy with developmental delay and congenital anomaliesBirgitta Gläser, Eva Rossier, Gotthold Barbi, et al.
Pageof 9

Showing results (11-20 of 89) with videos related to

Sort By:
Pageof 9
Annals of Hematology|May 4, 2007
Ifosfamide, epirubicin, and etoposide (IEV) mobilize peripheral blood stem cells more efficiently than cyclophosphamide/etoposideChristina Hart, Christian Blank, Stefan W Krause, et al.
Current Oncology Reports|February 25, 2012
Immunological heterogeneity of the RCC microenvironment: do targeted therapies influence immune response?Axel Bex, Tamara Etto, Florry Vyth-Dreese, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 22, 2003
Absence of programmed death receptor 1 alters thymic development and enhances generation of CD4/CD8 double-negative TCR-transgenic T cellsChristian Blank, Ian Brown, Reinhard Marks, et al.
European Journal of Immunology|August 7, 2009
Homeostatic proliferation of naïve CD8+ T cells depends on CD62L/L-selectin-mediated homing to peripheral LNKerstin Schuster, Jules Gadiot, Reinhard Andreesen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 8, 2005
ICAM-1 contributes to but is not essential for tumor antigen cross-priming and CD8+ T cell-mediated tumor rejection in vivoChristian Blank, Ian Brown, Aalok K Kacha, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2006
Homeostatic proliferation as an isolated variable reverses CD8+ T cell anergy and promotes tumor rejectionIan E Brown, Christian Blank, Justin Kline, et al.
Urology|August 2, 2011
A phase II study of presurgical sunitinib in patients with metastatic clear-cell renal carcinoma and the primary tumor in situAxel Bex, Christian Blank, Wim Meinhardt, et al.
World Journal of Urology|February 3, 2016
Comparison of pre-treatment MSKCC and IMDC prognostic risk models in patients with synchronous metastatic renal cell carcinoma treated in the era of targeted therapyAllard Noe, Roderick E de Bruijn, Christian Blank, et al.
Immunological Reviews|September 16, 2006
Immune resistance orchestrated by the tumor microenvironmentThomas F Gajewski, Yuru Meng, Christian Blank, et al.
American Journal of Medical Genetics. Part A|December 12, 2002
Molecular cytogenetic analysis of a constitutional de novo interstitial deletion of chromosome 12p in a boy with developmental delay and congenital anomaliesBirgitta Gläser, Eva Rossier, Gotthold Barbi, et al.
Pageof 9